|1.||Grobbee, Diederick E: 1 article (05/2014)|
|2.||Bonten, Marc J M: 1 article (05/2014)|
|3.||Roes, Kit C B: 1 article (05/2014)|
|4.||Oosterman, Bas J: 1 article (05/2014)|
|5.||Smorenburg, Andre J: 1 article (05/2014)|
|6.||Stockwell, Melissa S: 1 article (03/2014)|
|7.||Vellozzi, Claudia: 1 article (03/2014)|
|8.||Fernandez, Nadira: 1 article (03/2014)|
|9.||Sharma, Devindra: 1 article (03/2014)|
|10.||Barrett, Angela: 1 article (03/2014)|
05/23/2014 - "We therefore determined associations between patient related and study-related factors and study inclusion in healthy elderly (>65 years) invited to participate in a double-blind placebo-controlled randomized study to determine effectiveness and safety of a 13-valent pneumococcal vaccine for community-acquired pneumonia in the Netherlands. "
|2.||Febrile Seizures (Febrile Seizure)
03/01/2014 - "An observational study found an increased risk of febrile seizure on the day of or 1 day after vaccination (days 0-1) with trivalent inactivated influenza vaccine (TIV) in the 2010-2011 season; risk was highest with simultaneous vaccination with TIV and 13-valent pneumococcal vaccine (PCV13) in children who were 6 to 23 months old. "
|1.||Influenza Vaccines (FluMist)